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Connective tissueThe present study was designed to demonstrate the potential of an optimized histology directed protein identi-
ﬁcation combined with imaging mass spectrometry technology to reveal and identify molecules associated to
ectopic calciﬁcation in human tissue. As a proof of concept, mineralized and non-mineralized areas were
compared within the same dermal tissue obtained from a patient affected by Pseudoxanthoma elasticum, a
genetic disorder characterized by calciﬁcation only at speciﬁc sites of soft connective tissues. Data have been
technically validated on a contralateral dermal tissue from the same subject and compared with those from
control healthy skin. Results demonstrate that this approach 1) signiﬁcantly reduces the effects generated by
techniques that, disrupting tissue organization, blend data from affected and unaffected areas; 2) demonstrates
that, abolishing differences due to inter-individual variability, mineralized and non-mineralized areas within the
same sample have a speciﬁc protein proﬁle and have a different distribution of molecules; and 3) avoiding the
bias of focusing on already known molecules, reveals a number of proteins that have been never related to the
disease nor to the calciﬁcation process, thus paving the way for the selection of new molecules to be validated
as pathogenic or as potential pharmacological targets.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Calcium and phosphate deposition in soft connective tissues occurs
in a number of genetic diseases, in metabolic disorders, such as uremia,
hyperparathyroidism and diabetes, or secondary to inﬂammation
or atherosclerosis. Numerous proteins have been identiﬁed to be
involved in bone calciﬁcation as well as in ectopic mineralization,
suggesting that an active and dynamic balance of pro-calcifying and
anti-calcifying mechanisms takes place in both physiological and
pathological calciﬁcations [1]. Nevertheless it is still unclear whether
calciﬁcation affects particularmatrix components in speciﬁc organs/tis-
sues, whereas other areas remain unaffected and which molecules/
pathways could be targeted for pharmacological approaches. To address
these questions, investigations performed so far have looked at the spe-
ciﬁc expression/localization of already known proteins [2] or have used
cell lines and tissue extracts to pick up unknown gene/proteins by, Via Campi 287, 41125Modena,
lino).
. This is an open access article undermeans of “omic” techniques [3–5]. However, the major difﬁculty of
these techniques is the ability to analyze a large number of proteins
without losing the morphology and the tissue architecture and, even
more importantly, to discriminate which proteins belong to normal or
to pathologic areas. Therefore, in this study, on-tissue analyses were
carried out by Matrix-assisted laser desorption/ionization mass spec-
trometry (MALDI MS) (proﬁling and imaging) [6,7] as a consolidated
tool for the analysis of biological and clinical tissue samples [8–12].
This approach has several advantages: i) endogenous (locally synthe-
sized by cells) as well as exogenous (derived from the blood stream)
molecules can be analyzed directly from the tissue in their native envi-
ronment, without homogenization, thus preserving spatial relationship
of molecules within a specimen; ii) it does not require the use of anti-
bodies; and iii) it can map the expression of hundreds of proteins
from a single (8 μm thick) tissue section.
However, MALDI MS, although leading to the detection of a large
number of peptides and small proteins (up to 25 kDa), cannot be
currently utilized for larger proteins (exceeding 25 kDa). In order to
detect also proteins larger than 25 kDa, we have applied a histology-
directed mass spectrometry protein identiﬁcation [13] using hydrogel
discs as carriers for the enzyme, thus allowing the digestion to takethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Clinical phenotype and morphological features observed in PXE. (A–C) Skin laxity
(A) is associated to the presence of extended areas of calciﬁcation in the reticular dermis
as shown after von Kossa staining (B). By ultrastructural analyses (C) it appears that
mineral deposits (arrows) are present within elastic ﬁbers, thus altering their typical
amorphous structure (asterisk).
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between molecular information and tissue architecture.
As the technology advances, the application of MALDI MS as well
as of miniaturized hydrogel devices for histology directed on-tissue
protein digestion in the clinic will continue to expand, enabling to
play a central role in the diagnosis and prognosis of diseases and in
the evaluation of patient's therapy.
Therefore, we have combined this MS-based technology in order
to investigate skin biopsies from a patient affected by
Pseudoxanthoma elasticum, a rare genetic disorder characterized
by a progressive calciﬁcation occurring in speciﬁc areas of soft con-
nective tissues, whereas other regions remain unaffected [14]. Prote-
omic analyses were performed on mineralized and non-mineralized
areas of the same biopsy, and data compared with those from a con-
trol healthy tissue.
Material and methods
Tissue specimen collection
The patient was a woman 46 years old affected by Pseudoxanthoma
elasticum (PXE). The disease was clinically diagnosed at the age of
15 years by the presence of typical dermal alterations (Fig. 1A) and by oc-
ular angioid streaks. Biomolecular analyses conﬁrmed the clinical
diagnosis of PXE revealing two causative missense mutations in the
ABCC6 gene: one on exon 12 (c.1553GNA, p.Arg518Gln) and the other
on exon 24 (c.3389CNT, p.Thr1130Met).
Control tissue was obtained from a woman 47 years old undergoing
elective cosmetic surgical procedures. No connective tissue alterations
were present, nor any clinically relevant condition.
Consentwas obtained to use these specimens for research purposes in
accordance with the Declaration of Helsinki protocol.
After surgery, skin samples were immediately placed in ﬁxatives
for morphological analyses or frozen in liquid nitrogen and stored
at −80 °C until ready for processing and preparation for mass
spectrometry analysis.
Light and electron microscopy
For the demonstration of calciﬁed elastic ﬁbers, skin specimens (ap-
proximately 1 cm3) were routinely ﬁxed in 10% (v/v) formalin inwater,
dehydrated and embedded in parafﬁn. Five to seven micron thick sec-
tions were collected on glass slides and processed for the von Kossa
stain. Brieﬂy, sectionswere deparafﬁnized and hydrated, stained for ap-
proximately 1 h with 5% (w/v) silver nitrate in water under a UV-lamp,
rinsed with water, immersed for 5 min in 5% (w/v) thiosulfate in water
and ﬁnally observed with a Zeiss Axiophot light Microscope (Jena,
Germany).
For ultrastructural observations, specimens were cut in 1 mm3
fragments and routinely ﬁxed in 2.5% (v/v) glutaraldehyde (Agar
Scientiﬁc, Stansted, UK) in Tyrode's buffer pH 7.2 (135 mM NaCl,
2.8 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 12 mM NaHCO3, 0.4 mM
NaH2PO4, 5.5 mM Glucose), postﬁxed in 1% (v/v) osmium tetroxide
(Agar Scientiﬁc) in Tyrode's buffer, and dehydrated and embedded in
Spurr resin (Agar Scientiﬁc). Ultrathin sections (approximately
70–80 nm) were stained with uranyl acetate and lead citrate and
observed with a TEM Jeol 2010 (Jeol, Tokyo, Japan).
MS-based techniques: the strategy
A workﬂow of the analytical approach and technologies we have
combined in this study is presented in Fig. 2.
A typical experimental design forMALDIMSprotein analysis ismade
of 3 steps: sample preparation, data acquisition (proﬁling and imaging)
and data processing.In the proﬁling experiment, the laser beam irradiates each sam-
ple spot and ion signals from hundreds of consecutive shots are av-
eraged across the droplet surface generating a mass spectrum.
Protein patterns from a discrete number of spots or areas can be
compared allowing the analysis of molecules within their native
environment.
For imaging analyses (MALDI IMS), spectra are recorded for each
x,y coordinate into the mass range 2.5–30 kDa and ﬁnally plotted in
2-dimensions for ion density map construction (for each m/z
value). Hundreds of protein-speciﬁc ion density maps correlated
with tissue architecture can be generated. Each pixel (spectrum)
contains many proteins and endogenous peptides that are individually
displayed as a function of their position and relative intensity within
the tissue. Spectra from different regions of interest (i.e. papillary,
reticular and mineralized dermis) can be used for statistical analysis.
In a parallel experiment a histology-directed on-tissue protein
digestion approach has been applied. Brieﬂy, on-tissue protein di-
gestion was performed using hydrogel discs (1 mm in diameter em-
bedded with trypsin solution) placed on the regions of interest of
cryosectioned samples. After digestion, discs were ﬁrst manually re-
moved from the tissue surface, then properly treated (solvent ex-
tracted) and used for LC–MS/MS analysis followed by database
search for protein identiﬁcation (ID).
Fig. 2. Scheme of the approach for the analysis of ectopic calciﬁcation associated proteins by MALDI MS/IMS and histology-directed on-tissue digestion and protein identiﬁcation (ID).
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We have recently optimized techniques for IMS analysis of human
skin and have used only minor modiﬁcations of our published proce-
dures [15,16]. Fresh frozen human skin blocks (approximately 1 cm3)
were sectioned at 8 μmusing a cryostat (CM 3050 S, LeicaMicrosystems
GmbH, Wetzlar, Germany) set at−22 °C.
For MS analysis, serial cryosections were collected, mounted on ITO
conductive glass slides (Delta Technologies, Stillwater, MN) and
allowed to dry at room temperature for 3 min prior to matrix deposi-
tion. Each conductive slide was rinsed with Carnoy's (60 mL of ethanol,
30mL of chloroform, and 10mL of acetic acid) washing protocol [17] in
order to remove interfering species such as salts and lipids [18,19].
For histological orientation, serial cryosections were mounted on
glass microscope slides (Fisher Scientiﬁc, Pittsburgh, PA) and stained
with hematoxylin–eosin and alizarin red, respectively. Brieﬂy, slides
were placed in 95% ethanol (v/v) 30 s, puriﬁed water 30 s, hematoxylin
120 s, water 15 s, 70% ethanol (v/v) 15 s, 95% ethanol (v/v) 15 s, eosin
60 s, 95% ethanol (v/v) 15 s, 100% ethanol (v/v) 15 s, and xylenes
120 s. Calcium deposition was evaluated by alizarin red staining. Sec-
tions were washed at room temperature as follow: xylene (30 s), 90%
ethanol (v/v) (30 s), 70% ethanol (v/v) (30 s), puriﬁed water (30 s),alizarin red (100 μL, 30 s), acetone (15 s), acetone/xylene (1:1, v/v,
30 s) and ﬁnally xylene (3 × 30 s).
MALDI-MS
A crucial step in MALDI MS analyses is represented by the choice of
matrix type and of matrix deposition mode (e.g., droplet for proﬁling
by MALDI MS and thin homogenous matrix layer for imaging MALDI
MS). Most of the matrices are speciﬁc to a mass range or family of
compounds, moreover, each matrix type has speciﬁc ionization property
and this determines differences in the MS spectrum.
Sinapinic acid, for instance, is the matrix of choice for large proteins,
whereas α-cyano-4-hydroxy-cinnamic acid (CHCA) is the preferred
matrix for peptide mapping.
All MS analyses were performed by an AutoﬂexSpeed MALDI TOF
spectrometer (Bruker Daltonics, Billerica, MA, USA), equipped with a
linear TOF (time-of-ﬂight) analyzer, operating in positive polarity,
accumulating 500 laser shots per position in the case of the IMS
experiment, and 1000 shots per matrix spot in the case of the proﬁl-
ing experiment, at 1000 Hz laser frequency over the m/z range of
2500–30,000 Da. The laser intensity was adjusted before each
experiment to yield optimal results. Images were acquired at 50 μm
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Fig. 4. Principal component analysis (PCA) of spectra frompapillary and reticular dermis. (A) In control skin, protein distribution does not show a clear distinction betweenpapillary (blue)
and reticular (green)dermis. (B–C) In PXE, spectra from themineralized area (red) are distinctly separated from those obtained from thepapillary (blue) and thenon-mineralized reticular
(green) dermis.
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subtraction of each mass spectrum) and data visualization/process
veriﬁcation were performed using the Flex software suite (FlexControl
3.0, FlexAnalysis 3.0, FlexImaging 3.0) from Bruker Daltonics. Prior to
generation of ion density maps, spectra were normalized to the total ion
current (TIC) in order to minimize spectrum-to-spectrum differences in
peak intensity.
Tissue proﬁling by MALDI MS
A robotic acoustic droplet ejection system was used for matrix
deposition (Portrait 630 reagent multi-spotter, Labcyte, Sunnyvale, CA)
[20]. On an 8 μm-cryosection mounted on ITO conductive glass slide, 2
different areas of interest, papillary and reticular dermis (calciﬁed and
non-calciﬁed), were targeted for repeated deposition of matrix made
of sinapinic acid (20 mg/mL) in 1:1 acetonitrile/triﬂuoroacetic-acid
(Sigma Aldrich, St. Louis, MO, USA) at 0.1% (v/v) aq. that was deposited
over a series of 6 iterations at 10 droplets (120 nL) per iteration. After
the completion of matrix deposition, slides were immediately returned
to vacuum desiccation at room temperature until MS analysis the
same day (Fig. 2).
Tissue imaging by MALDI IMS
For imaging mass spectrometry, 8 μm-cryosections mounted on ITO
conductive glass slide were coated with a homogenous thin layer of
matrix using a sublimation device (Chemglass Life Science, Vineland,
NJ, USA). Sublimation of sinapinic acid (300 mg) was carried out at
145 °C, at a pressure of 45 mTorr and, after 15 min, coating became
uniform. The aim of this procedure was to allow themass spectrometer
to acquire spectra with a spatial resolution higher than that is possible
by an array of evenly spaced spots. Finally, tissue sections were quickly
rehydrated at 85 °C for 3 min to allow matrix recrystallization.
Protein identiﬁcation by LC–MS/MS
Tissue proteins were ﬁrst digested following a histology-directed in
situ digestion method using hydrogel discs for trypsin deposition onto
the speciﬁc tissue regions of interest (e.g.: dermis, mineralized dermis)
[21]. Digestion was performed at 50 °C for 4 h. Hydrogels (1 mmFig. 3. Protein analysis by MALDI MS. (A) Protein proﬁles were obtained by MALDI MS from pa
trace) in PXE skin. A close inspection of these proﬁles revealed that, some signals were common
sections after hematoxylin–eosin or alizarin red staining. (C) Seven representative density map
healthy and PXE dermis. Protein signals are depicted as color images with red representing thediameter) were re-hydrated for 15 min using 20 μL of 1 μg/mL
trypsin (in 100 mM ammonium bicarbonate) and then placed over
the tissue region of interest (skin mineralized dermis, adjacent
dermis) onto the whole tissue surface guided by the histological
features on corresponding serial H&E stained tissue section. The
tissue sections were incubated in an oven at 50 °C for 4 h to allow
protein digestion. Each hydrogel disc was removed from the tissue
section and placed in separate Eppendorf tubes. Peptides
imbibed into the microwell hydrogels were extracted by organic
(50% acetonitrile/5% formic acid) and aqueous (100 mM ammonium
bicarbonate) solvents, a process that was repeated three times. The
supernatants collected from each extraction were combined and
dried in a centrifugal vacuum concentrator (SPD Speedvac, Thermo
Scientiﬁc, Waltham, MA, USA). The reconstituted extracts (20 μL,
0.1% (v/v) formic acid) were stored at −20 °C until LC–MS/MS
analysis was performed.
The reconstituted extracts were analyzed by a 70 minute data
dependent LC–MS/MS analysis as already described [13]. Thus, MS/MS
spectra were searched via SEQUEST against a human database
(UniprotKB — reference proteome set) that also contained a reversed
version for each of the entries [22] (Fig. 2). The criteria used to accept
protein identiﬁcation included the extent of sequence coverage, the
number of matched peptides (almost 3 peptides/protein) and a
probabilistic score at p b 0.05 equivalent to 95% conﬁdence. All protein
identiﬁcations underwent false discovery rate (FDR) that measures
the expected proportion of false positives among the statistically
signiﬁcant ﬁndings. The FDR cutoff was set at 0% for all proteins in
Scaffold (Proteome Software).
Statistical analysis
Multiple spectra (N= 400) per region of interest (papillary dermis,
mineralized dermis, reticula dermis) were selected from the IMS data.
Comparisons of different cutaneous regions of interest were conducted
using principal component analysis (PCA) to generate classiﬁcation
models based on protein proﬁle patterns. In order to understand how
the molecular microenvironment within the mineralized dermis itself
can inﬂuence adjacent areas, PCA was performed comparing thepillary (blue trace), mineralized (red trace) and non-mineralized reticular dermis (green
to all 3 areas, whereas otherswere peculiar of a speciﬁc region. (B) Optical images of tissue
s were constructed on the basis of IMS data from an 8 μm thick sagittal section of control
highest relative intensity for each m/z value.
Table 1
List of proteins identiﬁed by histology-directed MS.
Short
name
Protein name Accession
no.
Short
name
Protein name Accession
no.
Proteins identiﬁed in the mineralized dermis
A2AP Alpha-2-antiplasmin P08697 HEP2 Heparin cofactor 2 P05546
AEBP1 Adipocyte enhancer-binding protein 1 Q8IUX7 MYPR Myelin proteolipid protein P60201
APOE Apolipoprotein E P02649 PCOC1 Procollagen C-endopeptidase enhancer 1 Q15113
C1QC Complement C1q subcomponent subunit C P02747 PEDF Pigment epithelium-derived factor P36955
CAPG Macrophage-capping protein P40121 RL4 60S ribosomal protein L4 P36578
CFAI Complement factor I P05156 SPP24 Secreted phosphoprotein 24 Q13103
CO6A6 Collagen alpha-6(VI) chain A6NMZ7 SRPX Sushi repeat-containing protein SRPX P78539
FILA Filaggrin P20930 THRB Prothrombin P00734
H7C2N1 Prothymosin alpha (fragment) H7C2N1
Proteins identiﬁed in the non-mineralized dermis
AATM Aspartate aminotransferase, mitochondrial P00505 IMMT Mitochondrial inner membrane protein Q16891
ACON Aconitate hydratase, mitochondrial Q99798 K1C18 Keratin 18 P05783
ACOT2 Acyl-coenzyme A thioesterase 2, mitochondrial P49753 K22E Epidermal cytokeratin 2 P35908
ACSL1 Long-chain-fatty-acid–CoA ligase 1 P33121 K2C1B Keratin 1B Q7Z794
ADH1B Alcohol dehydrogenase 1B P00325 K2C7 Keratin 7 P08729
AK1C2 Aldo-keto reductase family 1 member C2 P52895 K2C8 Keratin 8, type II cytoskeletal P05787
AL9A1 4-Trimethylaminobutyraldehyde dehydrogenase P49189 KAD3 GTP:AMP phosphotransferase, mitochondrial Q9UIJ7
ALDH2 Aldehyde dehydrogenase, mitochondrial P05091 KAP3 cAMP-dependent protein kinase type II-beta
regulatory subunit
P31323
ANXA3 Annexin A3 P12429 LAMA4 Laminin subunit alpha-4 Q16363
ANXA4 Annexin A4 P09525 LAMB2 Laminin subunit beta-2 P55268
ANXA7 Annexin A7 P20073 LAMC1 Laminin subunit gamma-1 P11047
AOC3 Membrane primary amine oxidase Q16853 LDHB L-Lactate dehydrogenase B chain P07195
AT2B4 Plasma membrane calcium-transporting ATPase 4 P23634 LIPS Hormone-sensitive lipase Q05469
ATPO ATP synthase subunit O, mitochondrial P48047 MARCS Myristoylated alanine-rich C-kinase substrate P29966
BLVRB Flavin reductase (NADPH) P30043 MDHC Malate dehydrogenase, cytoplasmic P40925
CAH1 Carbonic anhydrase 1 P00915 MYL6 Myosin light polypeptide 6 P60660
CALR Calreticulin P27797 NCALD Neurocalcin-delta P61601
CD44 CD44 antigen P16070 NUCL Nucleolin P19338
DECR 2,4-Dienoyl-CoA reductase, mitochondrial Q16698 PEBP1 Phosphatidylethanolamine-binding protein 1 P30086
EF2 Elongation factor 2 P13639 PHB Prohibitin P35232
EFTU Elongation factor Tu, mitochondrial P49411 PIP Prolactin-inducible protein P12273
ESYT1 Extended synaptotagmin-1 Q9BSJ8 PLIN1 Perilipin-1 O60240
F213A Redox-regulatory protein FAM213A Q9BRX8 PLIN4 Perilipin-4 Q96Q06
FABP4 Fatty acid-binding protein, adipocyte P15090 PRDBP Protein kinase C delta-binding protein Q969G5
FAS Fatty acid synthase P49327 PRDX3 Thioredoxin-dependent peroxide reductase,
mitochondrial
P30048
FBN1 Fibrillin-1 P35555 RAB5C Ras-related protein Rab-5C P51148
FLNB Filamin-B O75369 RAP1B Ras-related protein Rap-1b P61224
G6PI Glucose-6-phosphate isomerase P06744 RBY1B RNA-binding motif protein, Y chromosome,
family 1 member B
A6NDE4
GNAS2 Guanine nucleotide-binding protein G(s) subunit alpha
isoforms short
P63092 RL13 60S ribosomal protein L13 P26373
GPDA Glycerol-3-phosphate dehydrogenase [NAD(+)],
cytoplasmic
P21695 S12A2 Solute carrier family 12 member 2 P55011
GRP75 Stress-70 protein, mitochondrial P38646 SDPR Serum deprivation-response protein O95810
HBD Hemoglobin subunit delta P02042 SEPT7 Septin-7 Q16181
HMGB1 High mobility group protein B1 P09429 SPB6 Serpin B6 P35237
HNRH1 Heterogeneous nuclear ribonucleoprotein H P31943 SRBS1 Sorbin and SH3 domain-containing protein 1 Q9BX66
HP183 Heterochromatin protein 1-binding protein 3 Q5SSJ5 TCP4 Activated RNA polymerase II transcriptional
coactivator p15
P53999
HYEP Epoxide hydrolase 1 P07099 TENS1 Tensin-1 Q9HBL0
IDHP Isocitrate dehydrogenase [NADP], mitochondrial P48735 TKT Transketolase P29401
IGHG3 Ig gamma-3 chain C region P01860 UBA1 Ubiquitin-like modiﬁer-activating enzyme 1 P22314
ILF2 Interleukin enhancer-binding factor 2 Q12905 XRCC6 X-ray repair cross-complementing protein 6 P12956
Proteins identiﬁed in mineralized and non-mineralized dermis
(common)
1433B 14-3-3 protein beta/alpha P31946 HS90A Heat shock protein HSP 90-alpha P07900
1433E 14-3-3 protein epsilon P62258 HSP71 Heat shock 70 kDa protein 1A/1B P08107
A1AG1 Alpha-1-acid glycoprotein 1 P02763 HSP7C Heat shock cognate 71 kDa protein P11142
A1AT Alpha-1-antitrypsin P01009 HSPB1 Heat shock protein beta-1 P04792
A2BHY4 Complement component C4B A2BHY4 HTTP Haptoglobin P00738
A2MG Alpha-2-macroglobulin P01023 IC1 Plasma protease C1 inhibitor P05155
AACT Alpha-1-antichymotrypsin P01011 IGHA1 Ig alpha-1 chain C region P01876
ACTB Actin, cytoplasmic 1 P60709 IGHG1 Ig gamma-1 chain C region P01857
ACTC Actin, alpha cardiac muscle 1 P68032 IGHG2 Ig gamma-2 chain C region P01859
ACTN1 Alpha-actinin-1 P12814 IQGA1 Ras GTPase-activating-like protein IQGAP1 P46940
ACTN4 Alpha-actinin-4 O43707 ITIH1 Inter-alpha-trypsin inhibitor heavy chain H1 P19827
AHNK Neuroblast differentiation-associated protein AHNAK Q09666 K1C10 Keratin 10 P13645
ALBU Serum albumin P02768 K1C14 Keratin 14 P02533
ANT3 Antithrombin-III P01008 K1C19 Keratin 19 P08727
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Table 1 (continued)
Short
name
Protein name Accession
no.
Short
name
Protein name Accession
no.
ANXA1 Annexin A1 P04083 K1C9 Keratin 9 P35527
ANXA2 Annexin A2 P07355 K2C1 Keratin 1 P04264
ANXA5 Annexin A5 P08758 K2C5 Keratin 5 P13647
ANXA6 Annexin A6 P08133 K2C6A Keratin 6A P02538
APOA1 Apolipoprotein A-I P02647 KCD12 BTB/POZ domain-containing protein KCTD12 Q96CX2
ARF3 ADP-ribosylation factor 3 P61204 KPYM Pyruvate kinase isozymes M1/M2 P14618
ARPC4 Actin-related protein 2/3 complex subunit 4 P59998 LAC2 Ig lambda-2 chain C regions P0CG05
ASPN Asporin Q9BXN1 LDHA L-Lactate dehydrogenase A chain P00338
ATPA ATP synthase subunit alpha, mitochondrial P25705 LMNA Prelamin-A/C P02545
ATPB ATP synthase subunit beta, mitochondrial P06576 LUM Lumican P51884
BGH3 Transforming growth factor-beta-induced
protein ig-h3
Q15582 MDHM Malate dehydrogenase, mitochondrial P40926
CALD1 Caldesmon Q05682 MIME Mimecan P20774
CALM Calmodulin P62158 MOES Moesin P26038
CAP1 Adenylyl cyclase-associated protein 1 Q01518 MYH9 Myosin-9 P35579
CAV1 Caveolin-1 Q03135 MYO1C Unconventional myosin-Ic O00159
CFAH Complement factor H P08603 PDIA1 Protein disulﬁde-isomerase P07237
CLH1 Clathrin heavy chain 1 Q00610 PDIA3 Protein disulﬁde-isomerase A3 P30101
CLUS Clusterin P10909 PEPL Periplakin O60437
CO1A1 Collagen alpha-1(I) chain P02452 PGK1 Phosphoglycerate kinase 1 P00558
CO1A2 Collagen alpha-2(I) chain P08123 PGS1 Biglycan P21810
CO3 Complement C3 P01024 PGS2 Decorin P07585
CO3A1 Collagen alpha-1(III) chain P02461 PLEC Plectin Q15149
CO4A2 Collagen alpha-2(IV) chain P08572 PLSL Plastin-2 P13796
CO4A4 Collagen alpha-4(IV) chain P53420 POSTN Periostin Q15063
CO6A1 Collagen alpha-1(VI) chain P12109 PPIA Peptidyl-prolyl cis-trans isomerase A P62937
CO6A2 Collagen alpha-2(VI) chain P12110 PPIB Peptidyl-prolyl cis-trans isomerase B P23284
CO9 Complement component C9 P02748 PRDX1 Peroxiredoxin-1 Q06830
COEA1 Collagen alpha-1(XIV) chain Q05707 PRDX2 Peroxiredoxin-2 P32119
DPYL2 Dihydropyrimidinase-related protein 2 Q16555 PRELP Prolargin P51888
DPYL3 Dihydropyrimidinase-related protein 3 Q14195 PROF1 Proﬁlin-1 P07737
E9PCV6 Collagen alpha-3(VI) chain E9PCV6 PTMS Parathymosin P20962
ECHA Trifunctional enzyme subunit alpha, mitochondrial P40939 PTRF Polymerase I and transcript release factor Q6NZI2
EF1A1 Elongation factor 1-alpha 1 P68104 Q5TCU3 Tropomyosin 2 (Beta) Q5TCU3
ELN Elastin P15502 Q5VU59 Tropomyosin 3 Q5VU59
ENOA Alpha-enolase P06733 Q6ZN4A Tropomyosin 1 (Alpha), isoform CRA_f Q6ZN40
ENPL Endoplasmin P14625 RAB7A Ras-related protein Rab-7a P51149
F13A Coagulation factor XIII A chain P00488 RLA0 60S acidic ribosomal protein P0 P05388
F5GWP8 Junction plakoglobin F5GWP8 RLA2 60S acidic ribosomal protein P2 P05387
FIBA Fibrinogen alpha chain P02671 ROA2 Heterogeneous nuclear ribonucleoproteins
A2/B1
P22626
FIBB Fibrinogen beta chain P02675 RS4X 40S ribosomal protein S4, X isoform P62701
FIBG Fibrinogen gamma chain P02679 RS9 40S ribosomal protein S9 P46781
FINC Fibronectin P02751 SERPH Serpin H1 P50454
FLNA Filamin-A P21333 SH3L3 SH3 domain-binding glutamic acid-rich-like
protein 3
Q9H299
G3P Glyceraldehyde-3-phosphate dehydrogenase P04406 SODE Extracellular superoxide dismutase [Cu–Zn] P08294
GDIB Rab GDP dissociation inhibitor beta P50395 SPTB2 Spectrin beta chain, non-erythrocytic 1 Q01082
GELS Gelsolin P06396 SPTN1 Spectrin alpha chain, non-erythrocytic 1 Q13813
GLU2B Glucosidase 2 subunit beta P14314 TAGL Transgelin Q01995
GRP78 78 kDa glucose-regulated protein P11021 TBA1B Tubulin alpha-1B chain P68363
GSTP1 Glutathione S-transferase P P09211 TBA4A Tubulin alpha-4A chain P68366
H10 Histone H1.0 P07305 TBB4B Tubulin beta-4B chain P68371
H12 Histone H1.2 P16403 TBB5 Tubulin beta chain P07437
H2A1B Histone H2A type 1-B/E P04908 TENX Tenascin-X P22105
H2B1K Histone H2B type 1-K O60814 TERA Transitional endoplasmic reticulum ATPase P55072
H32 Histone H3.2 Q71DI3 TLN1 Talin-1 Q9Y490
H4 Histone H4 P62805 TPIS Triosephosphate isomerase P60174
HBA Hemoglobin subunit alpha P69905 TRFE Serotransferrin P02787
HBB Hemoglobin subunit beta P68871 VAPA Vesicle-associated membrane protein-associated protein A Q9P0L0
HEMO Hemopexin P02790 VIME Vimentin P08670
HNRPD Heterogeneous nuclear ribonucleoprotein D0 Q14103 VINC Vinculin P18206
HNRPK Heterogeneous nuclear ribonucleoprotein K P61978
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dermis from healthy subject. Protein spectra from the MALDI IMS se-
quences were compared. PCA was performed because this is a statistical
method commonly used to reduce the dimensionality of a multivariate
data set to lower dimensions while retaining most of the information by
displaying and ranking its variance within a data set. The PCA transforms
the original coordinate system (peaks) into the new coordinate system(PC). The new coordinates are called principal components or PCs; so,
the ﬁrst PC (PC1) points in the direction of the highest variance, while
the secondPC (PC2) points in the direction of the secondhighest variance.
This statistical tool was used to generate classiﬁcation models based on
protein proﬁle patterns. These data were used to conﬁrm the existence
of two disparate sub-regions within the dermis in Pseudoxanthoma
elasticum disorder affected subjects. The same statistical analysis was
90 D. Taverna et al. / Bone 74 (2015) 83–94carried out for the papillary and reticular dermis from a healthy subject.
Statistical analyses were carried out using ClinProTools software from
Bruker (Bruker Daltonics, Billerica, MA, USA).
Functional analysis
To discover the Gene Ontology (GO) categories with signiﬁcantly
enriched protein numbers, the MS identiﬁed proteins were processed
by the DAVID (Database for Annotation, Visualization and Integrated
Discovery) bioinformatics resource v. 6.7, freely available at http://
david.abcc.ncifcrf.gov. The signiﬁcance of “protein”-term enrichment
was assured by a modiﬁed Fisher's exact test with a p value b 0.01.
The protein list was also functionally evaluated applying the
UniProtKB/Gene Ontology/Biological Process data processing (http://
www.uniprot.org/).
The list of gene IDs of the differentially expressed spots identiﬁed
were used to perform functional analysis with DAVID 6.7. The list of
gene IDs was loaded into the online tool (http://david.abcc.ncifcrf.gov/
) clicking on Functional annotation clustering and selecting gene ID as
identiﬁer and gene list as list type. After submission of the list, functional
classiﬁcation was performed on the basis of Gene Ontology.
STRING 9.1 network analysis
Possible connections among identiﬁed proteins were analyzed by a
protein and gene network software. For each protein, UniProtKB entry
numbers and related gene names were acquired in UniProtKB and
used for network generation by the use of STRING 9.1 (http://www.Fig. 5.GO analysis of proteins identiﬁed by histology-directedMS. (A) Venn diagram showing t
17 proteins were uniquely identiﬁed within the mineralized dermis and 78 proteins were iden
biological processes (B), molecular functions (C) and cell components (D) for 242 identiﬁed prstring-db.org/) [23,24]. The UniProtKB entry numbers were inserted
into the input form as “multiple proteins” and “Homo sapiens” was
selected as the reference organism.
Results
Assessment of calciﬁed areas
Morphological analyses of PXE skin conﬁrm the typical accumulation
of deformed calciﬁed elastic ﬁbers in the middle reticular dermis, as
assessed by von Kossa staining on parafﬁn embedded tissue (Fig. 1B)
and by ultrastructural observations (Fig. 1C). As clearly shown in Fig. 1C
calciﬁed elastic ﬁbers are characterized by enlarged and tortuous shape
with irregular contour due to the progressive deposition of mineral
precipitates starting from the elastin core. Only few small normal areas
of amorphous elastin are visible at the periphery of the ﬁbers.
MALDI mass spectrometry and imaging mass spectrometry
MALDIMS protein proﬁling shows,within the same PXE specimen, a
number of m/z ions with differences in peak's relative intensity and
distribution depending on the areas considered (Fig. 3A).
To further implement these data, IMS analyses (Fig. 3C), integrated
with histological observations (Fig. 3B), were carried out on control
and PXE cryosectioned samples at the spatial resolution of 50 μm.
Hematoxylin–eosin staining and alizarin red staining were used to
visualize tissue morphology and calciﬁed areas, respectively (Fig. 3B).
PXE data have been technically validated on sections from thehat 147 proteinswere found in both themineralized and the non-mineralized areas, while
tiﬁed only in the region adjacent to the calciﬁed area. By DAVID it is possible to deﬁne GO
oteins (see also Supplementary Tables S2–S4).
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data must be combined in order to produce structural and molecular
information and to create molecular 2D maps. The distribution
and the relative expression of hundreds of m/z ions, withinFig. 6. Predicted protein–protein interaction (PPI) networks created by STRING 9.1. (A) Eviden
protein association. (B) Action PPI inwhich thedifferent line colors represent themodeof proteimorphologically different tissue regions, were displayed. For exam-
ple, calgizzarin (ion at m/z 11651) is mainly distributed close to
the epidermis without differences between control and PXE speci-
mens. In the case of thymosin beta-4 (TYB-4) (m/z 4965), thisce PPI in which the line color represents the types of evidence characterizing the protein–
n actions. Each circle indicates an individual proteinwith the recognized abbreviated name.
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mineralized region in both PXE samples, whereas it is localized with-
in the whole dermis in controls, as previously described in normal
healthy skin [15]. By contrast, the cleaved form of TYB-4 (m/z
4748) is always present in the papillary dermis, whereas it is absent
in the control reticular dermis and in the mineralized regions. Other
ions, as m/z 3183 and 3406, appear primarily localized within the
mineralized reticular dermis compared to control skin, whereas
others, as m/z 3429, are similarly distributed in the superﬁcial layer
of control and PXE skin, or are barely expressed as in the case of m/
z 15874 (Fig. 3C). These data indicate that a differential protein map-
ping may characterize PXE samples compared to healthy skin.
In order to highlight similarities and differences among ion pat-
terns, MALDI mass spectra recorded from different control and PXE
dermal regions were compared by principal component analysis
(PCA). When the resulting plot is colored based on the tissue region,
it appears that control skin molecules from the papillary and the re-
ticular dermis are largely intermingled and no sample grouping is
clearly evident (Fig. 4A).
By contrast, PCA plots show that, in PXE, proteins from the
mineralized skin can be grouped in a region clearly separated from
those derived either from the papillary (Fig. 4B) or the reticular non-
mineralized dermis (Fig. 4C). Only a few proteins were clearly
identiﬁed, most being characterized on the basis of their presence
within a mass range of 3–25 kDa.
Histology-directed identiﬁcation of proteins from mineralized and
non-mineralized tissue regions
The term “histology-directed” describes the use of histology
combined with MS techniques, conducted directly on serial and
consecutive tissue sections, for the evaluation of proteome changes
affecting a speciﬁc tissue region. By histology it is possible to investigate
the morphology of the tissue and to distinguish pathologic from
adjacent, presumably healthy, areas. For protein identiﬁcation we
have selected tissue regions according to the histology and then we
have placed hydrogel discs (microwell reactors containing trypsin)
within non-mineralized and mineralized areas of the same PXE
specimen.
All identiﬁed proteins (acronym, full name and SwissProt accession
number) are listed in Table 1 and divided according to their presence in
mineralized or in non-mineralized regions or in both areas. Additional
details on mass spectrometry data are provided in Supplementary
Table S1.
Gene Ontology (GO) classiﬁcation of identiﬁed proteins
Fig. 5A shows that out of 242 proteins, 78 (32%) have been identiﬁed
in the non-mineralized tissue, 147 (61%) in both mineralized and non-
mineralized dermis and 17 (7%) in the calciﬁed area. Moreover,
considering the nonexclusive localization criteria used in GO, proteins
can appear in several annotation terms within the GO categories
(i.e. biological process, molecular function and cellular component).
According to their contribution to one or to more biological
processes, identiﬁed proteins appear to be mainly involved in cellular
processes, cellular component organization and biogenesis, multicellular
organismal processes and in the response to stimulus (Fig. 5B and Supple-
mentary Table S2). As far as their molecular functions, most of the identi-
ﬁed proteins exhibit binding and structuralmolecular activity (Fig. 5C and
Supplementary Table S3).
Finally, on the basis of their localization, 78 proteins were in the
extracellular region and 166 in organelle structures (Fig. 5D and
Supplementary Table S4).
Despite their different distribution and functional properties, the
great majority of the identiﬁed proteins are actually related one to the
other, as clearly highlighted by the results of the analysis performedusing the STRING software. In Fig. 6 the predicted protein–protein
interaction (PPI) networks are shown based on evidence (Fig. 6A) and
actions (Fig. 6B), respectively. In the evidence and in the action PPI, the
type of evidence characterizing the protein–protein association and the
mode of action of proteins are described by lines of different colors.
Discussion
Ectopic calciﬁcation is a pathologic mineralization process of soft con-
nective tissues associated to a number of genetic as well as acquired dis-
orders frequently responsible for age-related clinical complications [25].
Within this context, Pseudoxanthoma elasticum, due to ABCC6 gene
mutations, is characterized by progressive calciﬁcation affecting,
through only partially known mechanisms, speciﬁc areas of soft
connective tissues, as the skin, blood vessels and Bruch's membrane in
the eye [14]. Abnormal expression of inhibitors of calciﬁcation as
matrix-Gla-protein, pyrophosphate, and fetuin-A [3,26–28] has been
related to the disease, however it is still unclearwhy, within each tissue,
there are areas of mineralization together with uncalciﬁed regions. It
has been suggested that unknown factors within soft connective tissues
may allow or counteract the deposition of mineral hydroxyapatite
crystals at speciﬁc sites [29].
PXE represents the perfect model to test the relevance of the
combined approach of MALDI MS (proﬁling and imaging) together
with histology-driven MS protein identiﬁcation to improve the charac-
terization of the diseased tissue and to investigate a large number of
proteins on a single tissue section. This aspect is crucial in the case of
reduced sample availability and represents a signiﬁcant improvement
compared to other techniques requiring to separately analyze larger
amount of tissue by histology, immunohistochemistry and/or proteo-
mics. Moreover, this approach avoids the bias of focusing on already
known molecules or to evaluate proteins without a precise separation
between affected (mineralized) and unaffected (non-mineralized)
areas within the same tissue specimen.
In particular, with respect to tissue architecture and morphology,
IMS can produce spatially resolved mass spectrometric data that can
be combined with histological observations. In addition, with a single
measurement, IMS allows the direct analysis of molecules/peptides' lo-
calization and of their relative intensity within the tissue. A different
protein distribution between PXE and control skin, as well as between
different regions within the same specimen has been demonstrated,
avoiding differences due to individual variability. One of the most
striking variation between PXE skin samples and control specimens is
the peculiar localization of TYB-4 in the PXE papillary dermis, whereas
protein expression is barely detectable in the mineralized reticular
dermis. TYB-4 exerts a protective role on ROS-mediated damages in
many cell types, including ﬁbroblasts [30]. The observation that its
expression is negligible in the calciﬁed dermis may indicate that the
mineralized tissue is more susceptible to oxidative stress. Consistently,
chronic perturbances of redox balance have been demonstrated
in vivo and in vitro in PXE [31,32], as well as in other conditions related
to ectopic calciﬁcation [33,34]. Moreover, PCA plots clearly show that
themineralized dermis is characterized by a peculiar proteomic proﬁle.
IMS measures molecules by their mass. Although this is sufﬁcient for
smaller analytes, such as lipids or peptides that can be directly identiﬁed
on the tissue itself, molecules with molecular weights larger than
25 kDa cannot be identiﬁed as easily [35].
To tackle this problem, we have therefore enzymatically treated the
tissue in order to cleave proteins into peptides that can be readily
ionized, detected and subsequently identiﬁed. In particular, we have
used a histology directed in situ digestion method using hydrogel discs
for the enzyme deposition onto the speciﬁc tissue region of interest
(Fig. 2) [21]. The presence/absence of proteins from the analyzed samples
depends on the enzyme used for the digestion and on the technique ap-
plied for the extraction. In our work we have used only trypsin, without
adding any reduction and alkylation agent. Therefore, the number of
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quence of this choice. Moreover, we have applied very stringent parame-
ters during the process of protein identiﬁcation. This approach may limit
the number of listed proteins, although increasing the reliability of the
identiﬁcation of detected proteins and therefore a comparative analysis
was done in the same experimental conditions on different areas of the
same sample. Trypsin digestion allowed to reveal hundreds of proteins in-
volved inmany biological processes or belonging to cellular and extracel-
lular components, however, we have preferred to list only 242 proteins
resulting fromthehigh stringent conditionsused in the identiﬁcationpro-
cess (conﬁdence for analyte identiﬁcation N95% and FDR set at 0%).
The presence of cellular and metabolic proteins common to all tissue
regions indicates that cells are spread within the tissue, independently
from the presence of calciﬁcation, as previously demonstrated by
morphological observations showingnumerousﬁbroblasts closed tomin-
eralized elastic ﬁbers [36]. Interestingly, it has to be underlined that 78
and 17 proteins appear characteristic of the non-calciﬁed and of themin-
eralized dermis, respectively. Since the enzyme used for digestion and the
stringency of the parameters applied for database searching, affect the
number of identiﬁed proteins, possibly because of the experimental con-
ditions used, some proteins already known to be involved in the calciﬁca-
tion process (i.e. alkaline phosphatase, ectonucleotide pyrophosphatase/
phosphodiesterase 1) were not detected, whereas others were clearly
identiﬁed.
For instance, carbonic anhydrase (CA2) is speciﬁcally associated to the
non-mineralized region, whereas it is absent from areas of ectopic calciﬁ-
cation. Interestingly, CA2 loss of function has been actually related to
osteopetrosis and to arterial and cerebral calciﬁcations [37]. Although
the clinical phenotype in PXE is not so severe as that described in
patients affected by osteopetrosis, nevertheless it could be suggested
that CA2 may be involved in a complex network of factors promoting or
inhibiting mineral precipitates through changes in the local environment
[38].
In the calciﬁed dermis we have demonstrated the presence of
molecules as ApoE, an apolipoprotein that, besides its role in lipid
metabolism, is considered a “pathologic chaperone” [39] promoting
the accumulation of insoluble proteins within the extracellular
compartment. In agreement with this ﬁnding, insoluble aggregates of
ﬁbrillar and amorphous proteins have been described in association to
calciﬁed elastic ﬁbers within the PXE dermis [29]. Elastic structures
interact with several matrix components, including minor collagens
[40]. To be noted that in the present study, alpha 1, 2 and 3 chains of
collagen type VI have been identiﬁed in both mineralized and non-
mineralized regions, whereas a newly discovered alpha 6 chain of colla-
gen type VI, whose biological role is still under investigation, appears
unexpectedly associated to the calciﬁed dermis. It has been proposed
that the alpha 6 chain could represent alternatively spliced variants
leading to abnormal collagen microﬁbrillar structures possibly related
to elastin-associated components [41,42]. If these changes represent
markers of extracellular matrix alterations, thus favoringmineral depo-
sition, it has been never explored andmay beworth of additional inves-
tigation on a larger number of specimens/subjects.
All data are technically reproducible since the same results were
obtained from the contralateral skin sample and therefore support the
rationale to further look at speciﬁc molecules/pathways. Moreover, as
the technology advances, the analysis of fresh frozen tissue at higher
spatial resolution provides new possibilities to investigate tissue
morphology at amolecular level using small amount of tissue, a require-
ment extremely important in the case of reduced sample availability.
Finally, the application of MALDI MS (proﬁling and imaging) as well
as of the miniaturized hydrogel devices for histology directed on-tissue
protein digestion allows us to expand the use of these approaches to the
clinic, paving theway for the selection of newmolecules to be validated
as pathogenic or as potential pharmacological target.
In conclusion, although validating the pathogenic role of speciﬁc mol-
ecules was not the purpose of the present study, these data, for the ﬁrsttime, demonstrate the signiﬁcance of these technical approaches for
studying ectopic calciﬁcation.
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